ALLO vs FENC: stock comparison and AI forecast
Allogene Therapeutics, Inc. (ALLO) and Fennec Pharmaceuticals Inc. (FENC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALLO Allogene Therapeutics, Inc.
- Market Cap
- $387M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
FENC Fennec Pharmaceuticals Inc.
- Price
- $10.54 +58.5% · 6M
- Market Cap
- $370M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ALLO and FENC have similar market capitalizations ($387M and $370M).
- FENC turns -5.5% of its revenue into net income, against -3566.7% for ALLO.
- FENC carries 0.78 times debt per unit of equity, against 0.26 times for ALLO.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALLO | FENC |
|---|---|---|
| Market Cap | $387M | $370M |
| P/B Ratio | 0.89x | 8.71x |
| EPS | $-0.77 | $-0.18 |
| Book Value/Share | $1.26 | $1.21 |
| Revenue/Share | – | $1.69 |
| FCF/Share | $-0.30 | – |
Profitability & Margins
| Metric | ALLO | FENC |
|---|---|---|
| ROE | -37.9% | -7.7% |
| ROA | -30.1% | -4.3% |
| ROIC | -34.8% | -1.8% |
| Operating Margin | -3886.1% | -1.9% |
| Net Margin | -3566.7% | -5.5% |
| EBT Margin | -3489.0% | -7.1% |
Financial Health
| Metric | ALLO | FENC |
|---|---|---|
| Current Ratio | 10.72x | 5.85x |
| Quick Ratio | – | 5.66x |
| D/E Ratio | 0.26x | 0.78x |
| Financial Leverage | 1.26x | 1.78x |
| Interest Coverage | -6.6x | 579.0x |
| Working Capital | $308M | $60M |
Cash Flow
| Metric | ALLO | FENC |
|---|---|---|
| Operating Cash Flow | -$102M | -$2M |
| Free Cash Flow | -$103M | – |
| Capital Spending | -$400K | – |
Operational Efficiency
| Metric | ALLO | FENC |
|---|---|---|
| Asset Turnover | – | 0.78x |
Income Statement
| Metric | ALLO | FENC |
|---|---|---|
| Total Revenue | – | $59M |
| Operating Income | -$180M | -$1M |
| Net Income | -$165M | -$3M |
| R&D Expense | $123M | $220K |
| SG&A Expense | – | $72M |
Dividend & Shareholder Information
| Metric | ALLO | FENC |
|---|---|---|
| Shares Outstanding | 345M | 35M |
| EPS Growth | – | -357.1% |
ALLO vs FENC: stock comparison and AI forecast
Which is bigger, ALLO or FENC?
ALLO and FENC have similar market capitalizations ($387M and $370M).
Which one does Intratio's AI model rank higher, ALLO or FENC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.